Access the latest clinical data and research findings published by Theraclone and our clinical partners.
Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice
Journal: Virology 2014, 462-463, 115–125
Authors: Stoddart AC; Cieplak W, Chan-Hui P-YC et al.
Efficacy and Safety of Treatment with an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
Journal: Journal of Infectious Diseases 2014, doi: 10.1093/infdis/jiu539
Authors: Ramos EL; Mitcham JM; Swiderek KM et al.
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
Journal: Immunity. 2014 May 15, vol 40, [Epub ahead of print on Apr 24]
Authors: Falkowska E, Le KM, Ramos A et al.
The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
Journal: PLOS Pathogens. 2013 Nov, vol 9, e1003754
Authors: Sok D, Laserson U, Laserson J et al.
Highly Potent HIV-specific Antibody Neutralization In Vitro Translate into Effective Protection against Mucosal SHIV Challenge In Vivo
Journal: Proceedings of the National Academy of Sciences. 2012 Nov 13, vol 109, page 18921-18925
Authors: Moldt B, Rakasz EG, Schultz N et al.
Broad Neutralization Coverage of HIV by Multiple Highly Potent Antibodies
Journal: Nature. 2011 Sep 22, vol 477, page 466-471
Authors: Walker LM, Huber M, Doores KJ et al.
Human Antibodies Reveal a Protective Epitope that is Highly Conserved Among Human and Nonhuman Influenza A Viruses
Journal: Proceedings of the National Academy of Sciences. 2010 July 13, vol 107, page 12658-12663
Authors: Grandea AG, Olsen OA, Cox TC et al.
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Journal: Science. 2009 Oct 9, vol 326, page 285-278
Authors: Walker LM, Phogat SK, Chan-Hui PY et al.